CITI TRENDS INC (CTRN) Stock Fundamental Analysis
USA - NASDAQ:CTRN - US17306X1028 - Common Stock
36.98 USD
+0.51 (+1.4%)
We assign a fundamental rating of 3 out of 10 to CTRN. CTRN was compared to 121 industry peers in the Specialty Retail industry. The financial health of CTRN is average, but there are quite some concerns on its profitability. CTRN does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year CTRN has reported negative net income.
CTRN had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CTRN reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: CTRN reported negative operating cash flow in multiple years.
1.2 Ratios
CTRN has a worse Return On Assets (-3.64%) than 65.29% of its industry peers.
CTRN has a Return On Equity (-14.70%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.64% | ||
| ROE | -14.7% | ||
| ROIC | N/A |
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-3.45%
ROE(5y)11.58%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CTRN has a Gross Margin of 39.75%. This is in the better half of the industry: CTRN outperforms 62.81% of its industry peers.
CTRN's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for CTRN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 39.75% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.05%
GM growth 5Y-0.3%
2. Health
2.1 Basic Checks
CTRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
CTRN has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for CTRN has been reduced compared to 5 years ago.
There is no outstanding debt for CTRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 3.06 indicates that CTRN is not in any danger for bankruptcy at the moment.
CTRN has a better Altman-Z score (3.06) than 71.07% of its industry peers.
There is no outstanding debt for CTRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.06 |
ROIC/WACCN/A
WACC9.32%
2.3 Liquidity
A Current Ratio of 1.13 indicates that CTRN should not have too much problems paying its short term obligations.
The Current ratio of CTRN (1.13) is worse than 67.77% of its industry peers.
A Quick Ratio of 0.43 indicates that CTRN may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.43, CTRN is in line with its industry, outperforming 42.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.43 |
3. Growth
3.1 Past
CTRN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -29.69%.
CTRN shows a small growth in Revenue. In the last year, the Revenue has grown by 3.32%.
Measured over the past years, CTRN shows a decrease in Revenue. The Revenue has been decreasing by -0.75% on average per year.
EPS 1Y (TTM)-29.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.73%
Revenue 1Y (TTM)3.32%
Revenue growth 3Y-8.76%
Revenue growth 5Y-0.75%
Sales Q2Q%8.04%
3.2 Future
Based on estimates for the next years, CTRN will show a very strong growth in Earnings Per Share. The EPS will grow by 24.07% on average per year.
The Revenue is expected to grow by 5.80% on average over the next years.
EPS Next Y78.17%
EPS Next 2Y45.99%
EPS Next 3Y33.26%
EPS Next 5Y24.07%
Revenue Next Year5.99%
Revenue Next 2Y5.68%
Revenue Next 3Y5.94%
Revenue Next 5Y5.8%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CTRN. In the last year negative earnings were reported.
CTRN is valuated quite expensively with a Price/Forward Earnings ratio of 61.45.
Based on the Price/Forward Earnings ratio, CTRN is valued a bit more expensive than the industry average as 61.16% of the companies are valued more cheaply.
When comparing the Price/Forward Earnings ratio of CTRN to the average of the S&P500 Index (22.99), we can say CTRN is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 61.45 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CTRN indicates a slightly more expensive valuation: CTRN is more expensive than 67.77% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 48.7 |
4.3 Compensation for Growth
CTRN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CTRN's earnings are expected to grow with 33.26% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.99%
EPS Next 3Y33.26%
5. Dividend
5.1 Amount
CTRN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:CTRN (10/27/2025, 11:50:38 AM)
36.98
+0.51 (+1.4%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners90.77%
Inst Owner Change0.61%
Ins Owners10.83%
Ins Owner Change1.01%
Market Cap307.30M
Revenue(TTM)782.72M
Net Income(TTM)-16642000
Analysts82.5
Price Target48.96 (32.4%)
Short Float %5.41%
Short Ratio4.05
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)103.13%
Min EPS beat(2)20.8%
Max EPS beat(2)185.47%
EPS beat(4)2
Avg EPS beat(4)-187.09%
Min EPS beat(4)-938.78%
Max EPS beat(4)185.47%
EPS beat(8)2
Avg EPS beat(8)-158.11%
EPS beat(12)5
Avg EPS beat(12)-68.98%
EPS beat(16)8
Avg EPS beat(16)-68.52%
Revenue beat(2)1
Avg Revenue beat(2)0.11%
Min Revenue beat(2)-0.73%
Max Revenue beat(2)0.95%
Revenue beat(4)1
Avg Revenue beat(4)-1.15%
Min Revenue beat(4)-2.67%
Max Revenue beat(4)0.95%
Revenue beat(8)1
Avg Revenue beat(8)-2.27%
Revenue beat(12)3
Avg Revenue beat(12)-1.49%
Revenue beat(16)5
Avg Revenue beat(16)-1.86%
PT rev (1m)0%
PT rev (3m)24.68%
EPS NQ rev (1m)10.23%
EPS NQ rev (3m)12.71%
EPS NY rev (1m)0%
EPS NY rev (3m)19.01%
Revenue NQ rev (1m)0.91%
Revenue NQ rev (3m)2.57%
Revenue NY rev (1m)0.32%
Revenue NY rev (3m)1.28%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 61.45 | ||
| P/S | 0.39 | ||
| P/FCF | N/A | ||
| P/OCF | 101.32 | ||
| P/B | 2.71 | ||
| P/tB | 2.71 | ||
| EV/EBITDA | 48.7 |
EPS(TTM)-2.97
EYN/A
EPS(NY)0.6
Fwd EY1.63%
FCF(TTM)-1.11
FCFYN/A
OCF(TTM)0.36
OCFY0.99%
SpS94.19
BVpS13.63
TBVpS13.63
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.64% | ||
| ROE | -14.7% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 39.75% | ||
| FCFM | N/A |
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-3.45%
ROE(5y)11.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.05%
GM growth 5Y-0.3%
F-Score6
Asset Turnover1.71
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 67.5% | ||
| Cap/Sales | 1.57% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 58.46% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.43 | ||
| Altman-Z | 3.06 |
F-Score6
WACC9.32%
ROIC/WACCN/A
Cap/Depr(3y)80.1%
Cap/Depr(5y)94.79%
Cap/Sales(3y)2.05%
Cap/Sales(5y)2.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.73%
EPS Next Y78.17%
EPS Next 2Y45.99%
EPS Next 3Y33.26%
EPS Next 5Y24.07%
Revenue 1Y (TTM)3.32%
Revenue growth 3Y-8.76%
Revenue growth 5Y-0.75%
Sales Q2Q%8.04%
Revenue Next Year5.99%
Revenue Next 2Y5.68%
Revenue Next 3Y5.94%
Revenue Next 5Y5.8%
EBIT growth 1Y58.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year124.15%
EBIT Next 3Y45.71%
EBIT Next 5Y30.92%
FCF growth 1Y-388.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-78.34%
OCF growth 3YN/A
OCF growth 5YN/A
CITI TRENDS INC / CTRN FAQ
What is the fundamental rating for CTRN stock?
ChartMill assigns a fundamental rating of 3 / 10 to CTRN.
What is the valuation status of CITI TRENDS INC (CTRN) stock?
ChartMill assigns a valuation rating of 2 / 10 to CITI TRENDS INC (CTRN). This can be considered as Overvalued.
How profitable is CITI TRENDS INC (CTRN) stock?
CITI TRENDS INC (CTRN) has a profitability rating of 2 / 10.
What is the financial health of CITI TRENDS INC (CTRN) stock?
The financial health rating of CITI TRENDS INC (CTRN) is 6 / 10.
Is the dividend of CITI TRENDS INC sustainable?
The dividend rating of CITI TRENDS INC (CTRN) is 0 / 10 and the dividend payout ratio is 0%.